BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 26, 2011
View Archived Issues
Phase II SaTIS trial studies tirofiban in patients with ischemic stroke
Read More
Neurocrine Biosciences commences second phase II study of VAT2 inhibitor
Read More
Gene therapy for SCID-X1 results in sustained restoration of T-cell immunity in phase I/II trial
Read More
New 11-beta-HSD1 inhibitor shows promise to treat type 2 diabetes and complications
Read More
EMA begins review of orlistat-containing antiobesity medicines
Read More
Profectus gains access to technologies to advance rVSV-vectored vaccines
Read More
Phase I trial investigates intravenously infused oncolytic poxvirus in advanced solid tumors
Read More
SomaLogic discloses new aptamers binding to TNF receptor superfamily member 9
Read More
Japanese university patents novel antiviral glycosides
Read More
Phase II trial evaluates DCE-US to monitor response to TKI-258 therapy in renal cell carcinoma
Read More
Amakem presents new Rho-associated protein kinase inhibitors
Read More
Interim phase I data reported on AN-152 in prostate cancer
Read More
New RAR-related orphan receptor-gamma ligands claimed
Read More
FDA clears Iris' prognostic prostate cancer test
Read More
Helsinn and Eisai announce launch of phase III netupitant/palonosetron program
Read More
ALK updates on Mitizax in Europe and Japan
Read More
New trans-platinum complexes described by Spanish university researchers
Read More
Avastin approved for new indication in Japan
Read More
RegeneRx completes treatment in phase II RGN-259 study
Read More
CHMP issues opinion on Edarbi for essential hypertension
Read More
Rasitrio recommended for approval in E.U.
Read More
Medistem obtains FDA approval for clinical study of ERC stem cell product
Read More
Remicade approved in U.S. for new indication
Read More
StemCells completes first neural stem cell transplantation in phase I/II trial
Read More
Optimer Pharmaceuticals and Astellas gain CHMP recommendation for Dificid approval
Read More
Mitsubishi Tanabe Pharma obtains Japanese approval for Telavic
Read More